• Hydrocortisone: Glucocorticoid Hormone for Translational Ass

  2026-04-25

  Hydrocortisone stands out as a gold-standard glucocorticoid hormone for dissecting anti-inflammatory pathways, barrier function, and stress response in complex disease models. This article delivers actionable workflows, advanced troubleshooting, and strategic context bridging inflammation, neurodegeneration, and cancer stemness research.

• EdU Flow Cytometry Assay Kits (Cy3): Precision in Proliferat

  2026-04-24

  The EdU Flow Cytometry Assay Kits (Cy3) by APExBIO redefine cell proliferation analysis with click chemistry, enabling robust, multiplexed S-phase DNA synthesis detection. Learn how to optimize your workflow, troubleshoot common pitfalls, and leverage the latest translational research advances.

• Applied Cancer Research with LEE011 Succinate: Protocols & I

  2026-04-24

  Harnessing LEE011 succinate as a selective CDK inhibitor unlocks reproducible cell cycle manipulation and robust antineoplastic agent evaluation for HER2-positive breast cancer models. This guide dissects protocol design, troubleshooting, and key learnings from recent solubility research, ensuring your cancer research workflows are both cutting-edge and reliable.

• OTC-Driven Ornithine Regulation in Realgar Neurotoxicity Rev

  2026-04-23

  This study uncovers a mechanistic link between realgar-induced arsenic toxicity and central nervous system (CNS) dysfunction, mediated by hepatic ornithine metabolism and astrocytic glycolysis regulation. It establishes the OTC–ornithine–ZBTB7A axis as a critical pathway in liver–brain communication during arsenic exposure, providing new avenues for metabolic neurotoxicology research.

• 0.4% Trypan Blue Solution: Technical Guide for Cell Viabilit

  2026-04-23

  0.4% Trypan Blue Solution enables direct discrimination between live and dead cells in cell viability and cytotoxicity assays. It is designed for research workflows requiring precise, reproducible assessment of cell membrane integrity, but should not be used for diagnostic or clinical purposes. Appropriate protocol setup and product handling are critical for optimal results.

• Shufeng Xingbi Therapy Modulates Th1/Th2 Balance & Microbiot

  2026-04-22

  This study demonstrates that Shufeng Xingbi Therapy restores Th1/Th2 immune balance and beneficially alters the gut microbiota in a rat model of allergic rhinitis. The work integrates immunological and microbiome analyses, offering mechanistic insight into the anti-inflammatory effects of this traditional therapy and potential research pathways for immune modulation.

• Fingolimod (FTY720): Evidence & Protocols for S1P Modulation

  2026-04-22

  Fingolimod (FTY720) is a potent immunomodulatory agent for MS, acting as a sphingosine-1-phosphate receptor modulator with high affinity for S1P1, S1P3, S1P4, and S1P5. Its unique mechanism restricts lymphocyte egress and promotes neuroprotection, with documented efficacy in both clinical and preclinical settings.

• Fluorescein TSA Fluorescence System Kit: Amplifying Detectio

  2026-04-21

  The Fluorescein TSA Fluorescence System Kit enables ultrasensitive fluorescence detection in immunohistochemistry and related assays. By leveraging HRP-catalyzed tyramide signal amplification, the kit allows robust visualization of low-abundance biomolecules. This article details its mechanism, evidence base, and integration into research workflows.

• MK-2206 dihydrochloride: Precision in PI3K/Akt Pathway Resea

  2026-04-21

  MK-2206 dihydrochloride empowers researchers to dissect the PI3K/Akt/mTOR signaling pathway with exceptional selectivity, enabling robust apoptosis assays and synergy studies. Its unique pharmacological profile, validated in advanced experimental models, streamlines troubleshooting and enhances reproducibility in cancer and immunology research.

• Imeglimin Restores Mitochondrial Function in Carpal Tunnel S

  2026-04-20

  This study demonstrates that Imeglimin enhances mitochondrial function in subsynovial connective tissue (SSCT) cells from patients with idiopathic carpal tunnel syndrome (CTS). Using multimodal assays, the research links improved mitochondrial biogenesis and antioxidant capacity to reduced apoptosis, supporting new therapeutic avenues for mitochondrial dysfunction in CTS.

• PKM2 Enhances Pulmonary Fibrosis via TGF-β1 Receptor Stabili

  2026-04-20

  This study reveals that pyruvate kinase M2 (PKM2) aggravates pulmonary fibrosis by stabilizing the TGF-β1 type I receptor through direct interaction with Smad7, thereby intensifying TGF-β1 signaling. These mechanistic insights provide new perspectives on fibrosis progression and highlight PKM2 as a potential molecular target for therapeutic intervention.

• Estradiol, ER Stress, and CD4+ T Cell Recovery Post-Hemorrha

  2026-04-19

  This study reveals that estradiol, via estrogen receptor-α (ERα) and GPR30, restores proliferation and cytokine function of splenic CD4+ T lymphocytes following hemorrhagic shock by inhibiting endoplasmic reticulum stress (ERS). The findings highlight the immunomodulatory potential of ER signaling in trauma-induced immune dysfunction and offer mechanistic clarity for endocrine modulation strategies.

• D-Lin-MC3-DMA: Redefining RNA Therapeutics with Smart Lipids

  2026-04-18

  This article provides an advanced, evidence-backed exploration of D-Lin-MC3-DMA as an ionizable cationic liposome for translational RNA delivery. It blends mechanistic insight, machine learning-driven optimization, and practical guidance for researchers developing siRNA and mRNA therapeutics—including vaccine, gene silencing, and immunochemotherapy applications. Key numeric claims are fully sourced. The article contextualizes APExBIO’s D-Lin-MC3-DMA within the evolving landscape, linking to established resources and escalating the discussion to strategic, cross-disciplinary considerations.

• GPER1 as a Chemopreventive Target in Prostate Cancer Progres

  2026-04-17

  This article examines the recent study identifying G-protein coupled estrogen receptor 1 (GPER1) as a potential chemoprevention target in prostate cancer. The work highlights dynamic GPER1 expression in disease progression, mechanistic links to epithelial-mesenchymal transition, and chemoprevention opportunities in high-grade prostatic intraepithelial neoplasia.

• Chloramphenicol for Plasmid Selection: Applied Workflows & T

  2026-04-16

  Chloramphenicol stands as a gold-standard bacterial protein synthesis inhibitor, excelling in stringent plasmid selection and advanced resistance studies. This article delivers evidence-based protocol enhancements, real-world troubleshooting, and actionable insights that enable scientists to leverage APExBIO’s high-purity Chloramphenicol for robust, reproducible molecular biology workflows.

16705 records 1/1114 page Next 12345 下5页 Last page